Combined SPECT/CT imaging using 123I-IMT in the detection of recurrent or persistent head and neck cancer

European Radiology

Volumn 16, Issue 2, 2006, Pages 503-511

  Plotkin, Michail ^a   Wurm, Reinhard ^a   Eisenacher, Julia ^a   Szerewicz, Katarzyna ^b   Michel, Roger ^a   Schlenger, Lorenz ^a   Pech, Maciej ^a   Denecke, Timm ^a   Kuczer, David ^a   Bischoff, Annet ^a   Felix, Roland ^a   Amthauer, Holger ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CENTRAL CLINICAL HOSPITAL   (Poland)

Author keywords

Amino acids; Head and neck cancer; L 3 123I iodine methyl tyrosine; Single photon emission tomography; Tumour imaging

Indexed keywords

ANTINEOPLASTIC AGENT; IODINE 123; METIROSINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; LOW ENERGY RADIATION; LYMPH NODE METASTASIS; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RECURRENT CANCER; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-METHYLTYROSINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; STATISTICS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 31544439916     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-005-2832-8     Document Type: Article

References (45)

1. Myers E, Leffall L (1991) Head and neck oncology: Diagnosis, treatment and rehabilitation. Little Brown, Boston
2. Bronstein AD, Nyberg DA, Schrarzt AN, Shuman WP, Griffin BR (1989) Soft-tissue changes after head and neck radiation: CT findings. Am J Neuroradiol 10:171-175
3. Som PM (1992) Detection of metastasis in cervical lymph nodes: CT and MR citeria and differential diagnosis. Am J Roentgenol 158:961-969
4. Chisin R (1999) Nuclear medicine in head and neck oncology: Reality and perspectives. J Nucl Med 40:91-95
5. Davis JP, Maisey NM, Chevreton EB (1998) Positron emission tomography: A useful imaging technique for otolaryngology, head and neck surgery? J Laryngol Otol 112:125-127
6. Baum U, Anders K, Steinbichler G, Lell M, Greess H, Riedel T, Kachelriess M, Kalender WA, Bautz WA (2004) Improvement of image quality of multislice spiral CT scans of the head and neck region using a raw data-based multidimensional adaptive filtering (MAF) technique. Eur Radiol 14:1873-1881
7. Lapela M, Grenman R, Kurki T, Joensuu H, Leskinen S, Lindholm P, Haaparanta M, Ruotsalainen U, Minn H (1995) Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy- D -glucose. Radiology 197:205-211
8. Farber LA, Benard F, Machtay M, Smith RJ, Weber RS, Weinstein GS, Chalian AA, Alavi A, Rosenthal DI (1999) Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 109:970-975
9. Fischbein NJ, AAssar OS, Caputo GR, Kaplan MJ, Singer MI, Price DC, Dillon WP, Hawkins RA (1998) Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol 19:1189-1196
10. Kao CH, ChangLai SP, Chieng PU, Yen RF, Yen TC (1998) Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 16:3550-3555
11. Wong RJ, Lin DT, Schoder H, Patel SG, Gonen M, Wolden S, Pfister DG, Shah JP, Larson SM, Kraus DH (2002) Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20:4199-4208
12. Yamada S, Kubota K, Kubota R, Ido T, Tamashashi N (1995) High accumulation of fluorine-fluorodeoxyglucose in terpentine-induced inflammatory tissue. J Nucl Med 36:1301-1306
13. Reinhardt MJ, Kubota K, Yamada S, Iwata R, Yaegashi H (1997) Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of flouorodeoxyglucose, L -methionine and thymidine. J Nucl Med 38:280-287
14. Hautzel H, Müller-Gärtner HW (1997) Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 38:1384-1386
15. Leskinen-Kallio S, Nagren K, Lehikoinen P, Ruotsalainen U, Teras M, Joensuu H (1992) Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 33:691-695
16. Lindholm P, Leskinen-Kallio S, Grenman R, Lehikoinen P, Nagren K, Teras M, Ruotsalainen U, Joensuu H (1995) Evaluation of response to therapy in head and neck cancer by positron emission tomography and [11C]methionine. Int J Radiat Oncol Biol Phys 32:787-794
17. Nuutinen J, Jyrkkio S, Lehikoinen P, Lindholm P, Minn H (1999) Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography. Radiother Oncol 52:225-232
18. Chesnay E, Babin E, Constans JM, Agostini D, Bequignon A, Regeasse A, Sobrio F, Moreau S (2003) Early response to chemotherapy in hypophyryngeal cancer: Assessment with (11)C-methionine PET. Correlation with morphologic response, and clinical outcome. J Nucl Med 44:526-532
19. Langen KJ, Coenen HH, Roosen N, Kling P, Muzik O, Herzog H, Kuwert T, Stöcklin G, Feinendegen LE (1990) SPECT studies of brain tumors with L -3-[123]iodo-a-methyltyrosine: Comparison with PET, 124IMT and first clinical results. J Nucl Med 31:281-286
20. Langen KJ, Ziemons K, Kiwit JCW, Herzog H, Kuwert T, Bock WJ, Stöcklin G, Feinendegen LE, Müller-G̈rtner HW (1997) 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]- L -methionine uptake in cerebral gliomas: A comparative study using SPECT and PET. J Nucl Med 38:517-522
21. Langen K-J, Pauleit D, Coenen HH (2002) 3-(123I)-Iodo-a-methyl- L -tyrosne: Uptake mechanisms and clinical applications. Nucl Med Biol 29:625-631
22. Dierickx LO, Everaert H, Deron P, Voordeckers M, Lahoutte T, Bossuyt A (2003) Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo- L -alpha-methyl tyrosine and single photon emission tomography. Nucl Med Commun 24:633-641
23. Flamen P, Bernheim N, Deron P, Caveliers V, Chavatte K, Franken PR, Bossuyt A (1998) Iodine-123 alpha-methyl-l-tyrosine single-photon emission tomography for the visualization of head and neck squamous cell carcinomas. Eur J Nucl Med 25:177-181
24. Dierickx LO, Lahoutte T, Deron P, Caveliers V, Vanhove C, Everaert H, Bossuyt A (2001) Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo- L -alpha-methyltyrosine SPET. Eur J Nucl Med 28:282-287
25. Tomura N, Watanabe O, Omachi K, Sakuma I, Takahashi S, Otani T, Kidani H, Watarai J (2004) Image fusion of thallium-201 SPECT and MR imaging for the assessment of recurrent head and neck tumors following flap reconstructive surgery. Eur Radiol 14:1249-1254
26. Krummreich C, Holsbach M, Stöcklin G (1994) Direkt electrophilic radioiodination of tyrosine analogues: Their in-vivo stability and brain uptake in mice. Appl Radiat Isotopes 45:929-935
27. 123I] iodo-α-methyl tyrosine and SPECT. J Nucl Med 30:110-112
28. Samnick S, Bader JB, Hellwig D, Moringlane JR, Alexander C, Romeike BF, Feiden W, Kirsch CM (2002) Clinical value of iodine-123-alpha-methyl- L -tyrosine single-photon emission tomography in the differential diagnosis or recurrent brain tumor in patients pretreated for glioma at follow-up. J Clin Oncol 15:396-404
29. Kuwert T, Woesler B, Morgenroth C, Lerch H, Schafers M, Palkovic S, Matheja P, Brandau W, Wassmann H, Schober O (1998) Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. J Nucl Med 39:23-27
30. Matheja P, Weckesser M, Rickert C, Franzius C, Palkovic S, Riemann B, Schober O (2002) I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours. Nuklearmediziner 41:191-196
31. 1H MR-spectroscopy at 3.0 Tesla in the differential diagnosis of recurrent or residual gliomas: A comparative study. J Neuro-oncol 70:49-58
32. 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours. Neuroradiology 47:18-26
33. Pauleit D, Floeth F, Tellmann L, Hamacher H, Hautzel H, Müller HW, Coenen HH, Langen KJ (2004) Comparison of O-(2-18F-fluoroethyl)- L -tyrosinePET and 3-123I-iodo-α-methyl-L-tyrosine SPECT in brain tumors. J Nucl Med 45:374-381
34. Jager PL, Franssen EJ, Kool W, Szabo BG, Hoekstra HJ, Groen HJ, de Vries EG, van Imhoff GW, Vaalburg W, Piers DA (1998) Feasibility of tumor imaging using L -3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors. J Nucl Med 39:1736-1743
35. Jager PL, Groen HJ, van der Leest A, van Putten JW, Pieterman RM, de Vries EG, Piers DA (2001) L -3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: Preliminary observations. J Nucl Med 42:579-585
36. Willkomm P, Bangard M, Guhlke S, Sartor J, Bender H, Gallkowski U, Reichmann K, Biersack HJ (2002) Comparison of [18F]FDG-PET and L -3[123I]-iodo-alpha-methyl tyrosine (I-123 IMT)-SPECT in primary lung cancer. Ann Nucl Med 16:503-506
37. Jager PL, Plaat BE, de Vries EG, Molenaar WM, Vaalburg W, Piers DA, Hoekstra HJ (2000) Imaging of soft-tissue tumors using L -3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: Comparison with proliferative and mitotic activity, cellularity, and vascularity. Clin Cancer Res 6:2252-2259
38. Jager PL, Meijer WG, Kema IP, Willemse PH, Piers DA, de Vries EG (2000) L -3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging. J Nucl Med 41:1793-1800
39. Steinert H, Boni R, Huch-Boni RA, Capaul R, von Schulthess GK, Westera G (1997) [123I]-alpha-methyltyrosine scintigraphy in malignant melanoma. Nuklearmediziner 36:36-41
40. 99mTc-hexakis-2-methoxyisobutylisonitrile. Eur J Nucl Med Mol Imaging 29:324-330
41. Ruf J, Lehmkuhl L, Bertram H, Sandrock D, Amthauer H, Humplik B, Munz DL, Felix R (2004) Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun 25:1177-1182
42. Pfannenberg AC, Eschmann SM, Horger M, Lamberts R, Vonthein R, Claussen CD, Bares R (2003) Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging 30:835-843
43. Kaczirek K, Prager G, Kienast O, Dobrozemsky G, Dudczak R, Niederle B, Kurtaran A (2003) Combined transmission and (99m)Tc-sestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmediziner 42:220-223
44. Ozer S, Dobrozemsky G, Kienast O, Beheshti M, Becherer A, Niederle B, Kainberger F, Dudczak R, Kurtaran A (2004) Value of combined XCT/SPECT technology for avoiding false positive planar (123)I-MIBG scintigraphy. Nuklearmediziner 43:164-170
45. Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, Lacau-Saint-Guily J, Laugier A, Schlienger M (1994) Synchronous and metachronous head and neck carcinomas. Cancer 74:1933-1938